Sonendo Celebrates One Million GentleWave® Procedures; Further Solidifies Its Position in Elevating the Patient Experience for Root Canal Treatment
December 06 2022 - 8:00AM
Business Wire
This Important Milestone Highlights Sonendo’s
Continued Commitment to Saving Teeth and Improving Lives
Sonendo, Inc. (NYSE: SONX), a leading dental technology company
and developer of the GentleWave® System, today announced that more
than one million patients have now been treated with the GentleWave
Procedure since the system entered the commercial market.
Redefining the standard of care for root canal therapy, the
GentleWave Procedure offers a minimally invasive process that
preserves tooth structure and promotes fast healing. A testament to
the continued adoption and utilization of the GentleWave System,
this latest milestone demonstrates doctors’ and patients’ growing
preferences for modern root canal treatment and technology that
puts the patient experience first.
In honor of this milestone, select GentleWave patients who
previously received the procedure returned to their endodontist,
Dr. Tadros M Tadros with Hudson Endodontics in Hudson, NH, to share
their positive experiences. As an avid user of the GentleWave
System since 2020, Dr. Tadros has treated more than 1,100 patients
with the GentleWave Procedure to date.
“I am honored to be a part of the community of GentleWave
doctors who have together treated more than one million patients.
The GentleWave System has completely transformed my practice since
implementation, and my patients can't stop talking about how the
GentleWave Procedure provided them with an experience that has
altered their expectations of root canal treatment,” said Dr.
Tadros. “The difference the GentleWave System has made for my
patients and my practice is something that I am incredibly proud
of, and I look forward to continuing my journey with this
technology in the months and years to come."
According to a recent survey conducted by Sonendo, more than 67%
of respondents agreed or strongly agreed with the following
statement: “I am terrified of getting a root canal procedure.” 77%
said that they would rather spend the night in the airport than
undergo root canal treatment and more than 80% said that the idea
of root canal treatment provoked a sense of fear. Unsurprisingly,
the idea of intense pain and a slow healing process can cause some
patients to avoid or postpone treatment – thereby compromising
their health. However, results from an ongoing clinical trial
sponsored by Sonendo indicate that 99.5% of patients experienced no
pain during the GentleWave Procedure with CleanFlow™ Technology. In
addition, once educated on the benefits of the GentleWave
Procedure, the vast majority of prospective patients indicated that
they would actively seek out a GentleWave Doctor.
“It's exciting for me to be a part of the GentleWave community
because this procedure completely altered my previous notions of
root canal treatment,” said Keri O of Hudson, NH, a patient of Dr.
Tadros. “To my surprise, the entire experience was significantly
less painful and overall easier than I expected. Not just during
the treatment, but in the days following the procedure as well. I
would certainly recommend Dr. Tadros and the GentleWave Procedure
to my friends and family – and let them know that there's nothing
to be afraid of or nervous about. Saving my natural tooth is a game
changer for me and means an overall improvement to my
well-being.”
This important milestone comes shortly after Sonendo announced
the release of its next generation GentleWave G4 System. With
Sonendo's patented technology at its core, the G4 System is
designed for an optimized doctor and patient experience with a
refined, simplified workflow – all while delivering an enhanced
level of clean that is only available with GentleWave
Technology.
“With a continued commitment to elevating patient care and
practice workflow through technological innovation, we are proud of
reaching this major milestone,” said Bjarne Bergheim, president and
CEO of Sonendo. “Our patients are at the core of everything we do,
and we are excited to continue on our growth trajectory. It’s
important to recognize that it’s the patient experience we are all
ultimately trying to elevate, and we are at the forefront of this
by supporting our doctors and enabling incredible outcomes for our
patients.”
For more information on the GentleWave System, doctors should
visit https://gentlewave.com/doctor/ and patients should visit
https://gentlewave.com/.
About Sonendo
Sonendo is a commercial-stage medical technology company focused
on saving teeth from tooth decay, the most prevalent chronic
disease globally. Sonendo develops and manufactures the GentleWave®
System, an innovative technology platform designed to treat tooth
decay by cleaning and disinfecting the microscopic spaces within
teeth without the need to remove tooth structure. The system
utilizes a proprietary mechanism of action, which combines
procedure fluid optimization, broad-spectrum acoustic energy and
advanced fluid dynamics, to debride and disinfect deep regions of
the complex root canal system in a less invasive procedure that
preserves tooth structure. The clinical benefits of the GentleWave
System when compared to conventional methods of root canal therapy
include improved clinical outcomes, such as superior cleaning that
is independent of root canal complexity and tooth anatomy, high and
rapid rates of healing and minimal to no post-operative pain. In
addition, the GentleWave System can improve the workflow and
economics of dental practices. Sonendo is also the parent company
of TDO® Software, the developer of widely used endodontic practice
management software solutions, designed to simplify practice
workflow. TDO Software integrates practice management, imaging,
referral reporting and CBCT imaging, and offers built-in
communication with the GentleWave System.
For more information about Sonendo and the GentleWave System,
please visit https://gentlewave.com/doctor/. To find a GentleWave
doctor in your area, please visit www.gentlewave.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221206005025/en/
MEDIA CONTACT: Sarah Gallagher Crowe PR sgallagher@crowepr.com
(224) 406-4709
Sonendo (NYSE:SONX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sonendo (NYSE:SONX)
Historical Stock Chart
From Apr 2023 to Apr 2024